1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsRolling deadline — applications accepted continuously. Page is hosted on Oxford University's translational research office site, describing Cancer Research Horizons Translation Fund and Early Validation Fund.
Translation Fund (including Early Validation Fund) is sponsored by Cancer Research Horizons (Cancer Research UK). The Translation Fund supports projects aiming to progress translational science with a clearly defined short to medium-term endpoint. It includes the Early Validation Fund, which de-risks very preliminary translational science.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Translation Fund | Cancer Research Horizons We want to help you answer the key questions that are preventing progress towards commercial development, from proof of concept studies to market research. What is the Translation Fund? The Translation Fund helps progress your project or bridge a gap to get your project to the next stage.
Proposals should have a clearly defined endpoint that is achievable in the short to medium term. The Translation Fund also includes the Early Validation Fund (formerly the Project Development Fund), which aims to de-risk very preliminary translational science. We don't restrict types of proposals, but they must be consistent with our vision and purpose.
Any projects fitting the above remit Open to both Cancer Research UK-funded and non-Cancer Research UK-funded researchers or projects Translation Fund: up to £250k per project Early Validation Fund: up to £80k per project If your proposal fits the above remit, reach our to your local Search & Evaluation representative to determine whether the scheme would be suited for your project.
They will also help you develop the key questions you have to ask before you take your project to the next level and help determine the best approach to answering them.
Regional Translation Lead Regional Translation Lead Explore other funding options Pre-seed and seed investment through our Seed Fund Accelerating high-potential, early-stage innovations into patient impact through seed funding, expert networks and business building support.
Translate your discoveries with the Cancer Research UK Therapeutic Catalyst Award For researchers with novel insights into cancer biology that can be targeted therapeutically to treat cancer. Maximise the impact of your data collected or generated under Cancer Research UK-funded research projects.
According to the current listing, eligibility includes: Any projects fitting the remit; open to both Cancer Research UK-funded and non-Cancer Research UK-funded researchers or projects. Confirm the full requirements in the official notice before applying.
The current listing shows up to £250,000 per project (Translation Fund); up to £80,000 per project (Early Validation Fund). Verify award ceilings, matching requirements, and allowable costs in the official notice.
Translation Fund (including Early Validation Fund) is funded by Cancer Research Horizons (Cancer Research UK). Verify program details on the funder's official page before applying.
Yes — this listing is flagged as national in scope, so applicants across the U.S. may apply, subject to the sponsor's other eligibility criteria.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
The Breast Cancer Research Foundation launched a $100 million venture philanthropy fund at CGI on September 22, 2026, seeded with $23 million and aiming at 20 to 30 companies. Here is what the structure actually means for investigators, for startups in the valley of death, and for every disease foundation now weighing the same move.
Read articleCDC-RFA-DP-27-0023 puts the National Breast and Cervical Cancer Early Detection Program, the National Comprehensive Cancer Control Program, and the National Program of Cancer Registries into a single competition closing February 5, 2027. Three statutorily separate eligibility pools, one application deadline, and an award count that maps onto the incumbent footprint. Here is how to read that.
Read articleCDMRP reissued the FY26 BCRP Breakthrough Award Levels 1 and 2 and the Clinical Research Extension Award on September 3, 2026, with a November 4 pre-application deadline and a November 18 full application deadline. Round one closed July 8. The arithmetic across both windows accounts for nearly the entire FY26 appropriation — which tells you what kind of second chance this is.
Read article